Viewing Expert Gordon Reid | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

Viewing Expert

Gordon Reid , President

GoodReid Investment Counsel

Address
47 Colborne Street
Suite 400
Toronto, ON
M5E 1P8

Contact Info
Telephone: 416.364.0890
Toll Free: 1.888.466.3734
Fax: 416.364.1788
Email:


Date Signal Chart Symbol Company Opinion Price
2016-05-03 N/A Must be logged in to use chart A Commentary A Comment -- General Comments From an Expert

Markets. We are on a teeter-totter in the sense that stocks are not cheap, but earnings are not that good either. We have seen earnings fail to outperform the previous year, 4 quarters in a row, and the next quarter is predicted to be another of those. We are in an earnings recession and are not seeing great earnings. The market has moved up modestly and is pretty much sideways, which is the way it should be. You want to reward good earnings. The correlation between earnings and stock price is the greatest predictor of where things are going. He is comfortable in a seesaw type of market, where good stock picking is rewarded. We are not totally rolling over as an economy. The economy is slow growth, but progressing. What really affects earnings are energy prices and foreign exchange, which tend to be transitory, not permanent. When that starts to turn around we’ll start to see a positive progression of corporate earnings. (You can look at a blog on his website at www.goodreid.com, where he discusses investing for the long-term.)


Price:
$0.020
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
_N/A
2016-05-03 HOLD Must be logged in to use chart AAPL-Q Apple

People either love it or really dislike it. He continues to like it. In the last 15 years, this stock has been halved 3 times. It’s not like it is different this time, but you always have to look into the future. This company, over time, is growing well. The latest quarter, which was an off cycle quarter, didn’t grow so well. While everybody wants to fit the equation of quarter to quarter, the product cycle of this company doesn’t work quarter to quarter. Had a fantastic introduction of the S model iPhone, where units grew 40%-45%, followed by the off cycle. Putting the 2 together you had a pretty good progression.


Price:
$95.180
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
Yes
2016-05-03 PAST TOP PICK Must be logged in to use chart AIRM-Q Air Methods Corp

(A Top Pick May 5/15. Down 18.53%.) In the air ambulance business. They have 2 areas of operation, contracting with people that need an air ambulance, and the community side where they work for hospitals transporting patients. Things tend to be fairly lumpy, but looking at a long-term progression it is a really good story. Not expensive.


Price:
$36.250
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
Yes
2016-05-03 COMMENT Must be logged in to use chart AMZN-Q Amazon.com

Difficult company to understand, because they tend not to be traditional. They don’t try to satisfy the street by returning capital to shareholders through dividends or buybacks. They don’t try to satisfy the street by having a progression of earnings over time.


Price:
$671.320
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
Unknown
2016-05-03 COMMENT Must be logged in to use chart BAC-N Bank of America

The best comparable to this would be Citigroup (C-N), which he owns. The whole banking sector is really going to move in tandem on a catalyst, which would be interest rates. Very cheap from a valuation standpoint. These will do well over time, but you have to be patient with them.


Price:
$14.360
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
No
2016-05-03 TOP PICK Must be logged in to use chart CRL-N Charles River Labs Intl

Does safety testing, the efficacy, phase 1 through 3 trials for particular drugs for pharmaceutical companies. High growth, growing earnings last year at 17%.


Price:
$78.800
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
Yes
2016-05-03 COMMENT Must be logged in to use chart CSX-Q CSX Corp

(Market Call Minute.) A little more exposed to coal, which is a negative. Operationally they have done a very good job bringing down their operating ratios.


Price:
$26.540
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
Unknown
2016-05-03 COMMENT Must be logged in to use chart FB-Q Facebook

The future is very, very bright. You are paying up on the expectation of future growth. Their numbers are astounding. They have 1.65 billion monthly users and well over 1 billion of active daily users.


Price:
$117.430
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
Yes
2016-05-03 DON'T BUY Must be logged in to use chart FCX-N Freeport McMoran Copper & Gold

This is a materials company, mostly in copper and some in gold. The issue he has is its debt, and how much of an issue that puts them in if we start to see some failure on the commodity side.


Price:
$12.010
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
No
2016-05-03 DON'T BUY Must be logged in to use chart GILD-Q Gilead Sciences Inc.

This makes him uncomfortable. He doesn’t like the concentration. They derive over 60% from their hepatitis C drugs, which have been very successful. There are a few issues. Very high cost at about $90,000 for a cure which is a 90-day script. A lot of people are after them to get the price down. There is also competition from other drugs. It is a cure, which is great from a social standpoint, but from a business standpoint do you want to invest in a company where the drug will no longer be needed.


Price:
$87.170
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
No
2016-05-03 DON'T BUY Must be logged in to use chart GM-N General Motors Corporation

(Market Call Minute.) This is a true cyclical, and you sell cyclicals when the PE is low, and buy them when the PE is high. Currently the PE is low, and the total auto sales is rolling over.


Price:
$31.250
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
Unknown
2016-05-03 PAST TOP PICK Must be logged in to use chart HD-N Home Depot

(A Top Pick May 5/15. Up 26.91%.), Have doubled their net profit margin over the last 7 years. Same-store sales are at around 7%, and total sales at around 10%. With low interest rates, people are forming homes at a faster rate. The company is in new homes as well as renovations and repairs.


Price:
$134.540
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
Yes
2016-05-03 DON'T BUY Must be logged in to use chart IBM-N IBM

(Market Call Minute.) Grew by cost cutting, which is a finite process. You can grow revenues to the moon, but you can only cut costs so much. It finally caught up and the stock rolled over. There are better opportunities elsewhere.


Price:
$144.130
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
Unknown
2016-05-03 COMMENT Must be logged in to use chart JNJ-N Johnson & Johnson

A fabulous company. Have had their hiccups over the years. They are in 3 major areas including consumers, devices and pharmaceutical. The pharmaceutical area has done the best, and is now pushing 45% of their business. Well-managed and a great balance sheet. Valuation is somewhat high at about 20X earnings.


Price:
$112.690
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
No
2016-05-03 COMMENT Must be logged in to use chart PFE-N Pfizer Inc

Just reported and had quite good earnings. They are reeling, of course, from the government decision to not allow the Allergan deal to go through. There is a lot of debate because the 2 companies were within the law, but the tax inversion issue is a big one, and the way it was done is leaving a bad taste in people’s mouths. Pfizer is just starting to move out of the issue of Lipitor coming off patent. It was a blockbuster drug before, but when it goes generic you see sales drop dramatically. Their pipeline has been building. This company has had basically flat revenues and earnings for 4 or 5 years, and is trading at about 20X earnings. A bit of a “show me” stock, and that goes for most pharmaceuticals. You are better off going into biotechs. Prices have come down quite dramatically, and are trading at cheaper multiples than Pharma drug companies. Have a look at Biogen (BIIB-Q) or Celgene (CELG-Q).


Price:
$33.700
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
Unknown
Showing 1 to 15 of 1,760 entries
<< < 1 2 3 4 5 > >>

No Comments.


You must be logged in to comment.